Clinical Trials Browser

Withdrawn × Carcinoma, Hepatocellular × anlotinib × Clear all

NCT04947371 2021-07-01

Adjuvant Therapy With Anlotinib for HCC

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular